Se espera que el mercado de aislamiento/separación de células crezca a una tasa anual compuesta del 16,87 % entre 2023 y 2029. En 2020, su valor era de 6890 millones de dólares y se espera que supere los 28 020 millones de dólares en 2029.
En muchas aplicaciones diferentes, como el diseño y desarrollo de productos biológicos, la fabricación de proteínas terapéuticas, los diagnósticos in vitro y otras aplicaciones de investigación, la separación de células es crucial. Los principales impulsores del crecimiento del mercado incluyen la mayor incidencia de enfermedades crónicas e infecciosas , incluido el cáncer y la COVID-19, y los continuos intentos del gobierno de impulsar el sector de la biotecnología.
El aislamiento celular se refiere al acto de extraer células individuales de una población diversa de células, una suspensión celular o tejidos. Al examinar tipos de células particulares o caracterizarlas, la técnica de aislamiento celular es esencial. Se realiza para contar células, realizar investigaciones de biología celular y preservar tipos de células particulares. El uso de técnicas de aislamiento celular en la producción sin complicaciones de numerosos tipos diferentes de productos biofarmacéuticos, como proteínas recombinantes, biosimilares y anticuerpos monoclonales, ha llevado a un aumento en la demanda de estas técnicas.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (miles de millones de USD) |
| Segmentación | Por producto, Por tipo de célula, Por técnica, Por aplicación, Por uso final |
| Por producto |
|
| Por tipo de célula |
|
| Por técnica |
|
| Por aplicación |
|
| Por uso final |
|
| Por región |
|
La separación de células es crucial para muchas aplicaciones diferentes, incluido el diseño y desarrollo de productos biológicos, la producción de proteínas terapéuticas, el diagnóstico in vitro y otras aplicaciones de investigación como la recolección de células tumorales circulantes en la sangre, el análisis molecular de poblaciones celulares particulares, el aislamiento de células inmunes de la sangre periférica, la preparación de una muestra de sangre separada del plasma, la separación de bacterias de los alimentos y la investigación de los efectos de los candidatos a fármacos en el comportamiento celular.
El uso de técnicas de aislamiento celular facilita el desarrollo de terapias basadas en células, lo que mejora la eficacia de la atención y el curso de la terapia. La innovación en la tecnología de aislamiento y separación de células, la creciente necesidad de productos biofarmacéuticos y tratamientos personalizados, el aumento de la investigación con células madre y el aumento de la incidencia y prevalencia de enfermedades crónicas con el envejecimiento de la población son algunos de los factores que impulsan el mercado. Durante el período proyectado, Asia y el creciente uso de la tecnología de microfluidos ofrecerán un potencial de mercado significativo.
Cell isolation/cell separation market is expected to grow at 16.87% CAGR from 2022 to 2029. it is expected to reach above USD 28.02 billion by 2029
North America held more than 35% of cell isolation/cell separation market revenue share in 2021 and will witness expansion in the forecast period.
In many different applications, such as the design and development of biologics, the manufacturing of therapeutic proteins, in-vitro diagnostics, and other research applications, cell separation is crucial. The primary drivers of market growth include the increased incidence of chronic and infectious diseases, including cancer and Covid-19, and ongoing government attempts to advance the biotechnology sector.
Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Danaher, Terumo Corporation, STEMCELL Technologies Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Philips Healthcare, Akadeum Life Sciences, Miltenyi Biotec, 10X Genomics, Carl Zeiss AG.
With a 30.8% revenue share in 2020, the biomolecule isolation sector dominated the market for cell separation. The primary factor influencing its largest share is the increased emphasis on the development of biopharmaceuticals, such as biosimilar, monoclonal antibodies, and recombinant proteins. The market is growing as a result of increased government financing for the development of new drugs.
Cell Isolation/Cell Separation Market is segmented based on product, cell type, technique, application, end-use and region, global trends and forecast.
By product the market is segmented into consumables and instruments. The consumables industry dominated the cell separation market in 2020, with 62.3% of total revenue. Due to frequent consumable purchases, this market group had the biggest share. Rising R&D expenditures by biotechnology and biopharmaceutical firms for the creation of sophisticated biologics, such as monoclonal antibodies and vaccines, are another factor driving the market. As a result, it is anticipated that during the projection period there would be a significant demand for consumables. Due to product advances, it is anticipated that the instruments category would increase at a profitable pace throughout the projection period. For use in research, diagnostics, and treatments, technological development in instrumentation allows for effective cell separation. As a result, it is expected that the instrument sector would expand significantly during the coming years.
By cell type the market is segmented into human cells and animal cells. The market for cell separation was dominated by the human cell category in 2020, with a revenue share of 44.8%. Numerous uses of isolated human cells in biopharmaceuticals development, clinical trials, and research, as well as an increased focus on human and cancer research, are some of the key drivers influencing the greatest share. During the projected period, the segment for animal cells is expected to increase at a profitable pace. A significant aspect influencing the segment's growth is the increasing attention that private, public, and healthcare companies are giving to the research and discovery of new drugs.
By technique the market is segmented into centrifugation, surface marker, filtration. With a 42.7% revenue share in 2020, the centrifugation segment dominated the cell separation market. This is a result of the widespread use of this technique by research facilities, biotechnology and pharmaceuticals corporations, as well as academic institutions. In the near future, it's anticipated that the filtration and surface marker segments will both experience significant expansion. Product improvements and growing corporate investments in manufacturing infrastructure are the main drivers of this market's expansion.
By application the market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, therapeutics. With a 30.8% revenue share in 2020, the biomolecule isolation sector dominated the market for cell separation. The primary factor influencing its largest share is the increased emphasis on the development of biopharmaceuticals, such as biosimilar, monoclonal antibodies, and recombinant proteins. Over the course of the study, it is anticipated that the stem cell and cancer research segments will grow profitably. An important element contributing to the segment growth is the increase in funding for cell-based research by businesses and academic institutions.
By end-use the market is segmented into research laboratories and institutes, hospitals and diagnostic laboratories, cell banks, biotechnology and biopharmaceutical companies. With a revenue share of 43.9% in 2020, the research laboratories and institutes segment had the greatest revenue share and is predicted to maintain that position over the course of the study. This can be linked to an increase in R&D projects undertaken by academic institutions to create new cancer and neurological medicines. It is also projected that a key driver of the industry will be the increasing number of research institutes and laboratories around the world.
[caption id="attachment_14753" align="aligncenter" width="1920"]
Cell Isolation/Cell Separation Market key players include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Danaher, Terumo Corporation, STEMCELL Technologies Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Philips Healthcare, Akadeum Life Sciences, Miltenyi Biotec, 10X Genomics, Carl Zeiss AG.
February 17, 2021: Thermo Fisher Scientific Inc., the world leader in serving science, announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently introduced Bigfoot Spectral Cell Sorter and approximately 40 employees will become part of Thermo Fisher's Biosciences business. Propel Labs will continue to operate as a separate entity and serve its existing customers.
December 1, 2020: Miltenyi Biotec launched new all-in-one kits for the efficient stimulation and functional analysis of SARS-CoV-2‒reactive T cells. Specifically developed for fast and rapid detection in PBMC samples after stimulation with the SARS-CoV-2 PepTivator® Peptide Pools released earlier this year, the kits represent decades worth of experience in developing solutions for virus-specific T cell research. Assessing such rare cells is essential for understanding fundamental immunological processes in infectious diseases, including COVID-19.
Cell Isolation/Cell Separation Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
North America dominated the cell separation market, holding the largest revenue share at 35% in 2021. This is due to the established pharmaceutical and biotech industries and the high acceptance of technologically advanced solutions in the United States. In addition, extensive research activities by research universities in the field of cell therapy have created a huge demand for cell separation solutions. Additionally, the high prevalence of chronic and infectious diseases, including the COVID-19 outbreak, has increased the demand for cell separation solutions for research and clinical applications.
In the Asia-Pacific region, the cell separation market is expected to grow significantly, owing to the growth of the pharmaceutical and biotechnology industries in emerging countries such as China and India. In addition, increasing healthcare spending and increasing market penetration by key global players in key Asia-Pacific countries are factors expected to drive the segment during the forecast period. In addition, ongoing strain and gene therapy research initiatives in Japan, China, and South Korea have further increased the demand for cell isolation solutions in the region.
[caption id="attachment_14756" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.